Coegin Pharma AB (NGM: COEGIN)
Health Care · Biotechnology · SE
Skr2.65
-7.67% today · -63.7% 1Y
Coegin Pharma AB (NGM: COEGIN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $7.55M.
Over the last twelve months the share price has lost 63.7%, trading between 2.62 and 7.58.
Tweenvest scores Coegin Pharma AB across four factors: quality 34/100, value 56/100. Its strongest factor is value.
COEGIN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.55M
- Revenue (TTM)
- $44.68K
- P/E
- —
- EPS
- -0.87
- Dividend yield
- —
- Beta (5Y)
- 0.93
- 52-week high
- Skr7.58
- 52-week low
- Skr2.62
- Avg volume (3M)
- —
- Shares outstanding
- 28.59M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Spago Nanomedical AB (publ)OM: SPAGO | $7.88M | Skr0.11 | +8.59% |
| Arctic Bioscience ASOB: ABS | $7.84M | Nkr2.76 | -1.43% |
| Enlivex Ltd.NasdaqCM: ENLV | $7.71M | $0.31 | -20.89% |
| Ensysce Biosciences, Inc.NasdaqCM: ENSC | $7.69M | $0.43 | +8.71% |
| AcouSort AB (publ)OM: ACOU | $7.55M | Skr3.00 | -16.20% |
| Exicure, Inc.NasdaqCM: XCUR | $7.53M | $1.02 | -11.30% |
| MOA Life Plus Co. Ltd.KOSDAQ: A142760 | $7.50M | ₩479.00 | +2.57% |
| KALA BIO, Inc.NasdaqCM: KALA | $7.45M | $0.36 | -6.49% |
Figures last refreshed Oct 4, 2026.